S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
Log in
NASDAQ:MGTX

MeiraGTx News Headlines

$15.85
+0.33 (+2.13 %)
(As of 02/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.95
Now: $15.85
$16.38
50-Day Range
$14.33
MA: $15.81
$16.83
52-Week Range
$8.82
Now: $15.85
$18.74
Volume91,646 shs
Average Volume112,785 shs
Market Capitalization$608.83 million
P/E RatioN/A
Dividend YieldN/A
Beta1.33

Headlines

MeiraGTx (NASDAQ MGTX) News Headlines Today

Source:
SourceHeadline
MeiraGTx (NASDAQ:MGTX) Shares Up 6.2%MeiraGTx (NASDAQ:MGTX) Shares Up 6.2%
americanbankingnews.com - February 19 at 8:02 PM
MeiraGTx Holdings plc (NASDAQ:MGTX) CEO Alexandria Forbes Sells 15,000 SharesMeiraGTx Holdings plc (NASDAQ:MGTX) CEO Alexandria Forbes Sells 15,000 Shares
americanbankingnews.com - February 18 at 7:00 PM
Applied Genetic Technologies: Leader Among Larger Peers In Gene Therapies For Certain Eye Diseases - Seeking AlphaApplied Genetic Technologies: Leader Among Larger Peers In Gene Therapies For Certain Eye Diseases - Seeking Alpha
seekingalpha.com - February 16 at 12:00 PM
Is MeiraGTx Holdings plc (NASDAQ:MGTX) Popular Amongst Insiders?Is MeiraGTx Holdings plc (NASDAQ:MGTX) Popular Amongst Insiders?
finance.yahoo.com - February 8 at 1:21 PM
MeiraGTx (NASDAQ:MGTX) Trading Up 7.6%MeiraGTx (NASDAQ:MGTX) Trading Up 7.6%
americanbankingnews.com - February 1 at 7:58 PM
Our First Look At MeiraGTx Holdings - Seeking AlphaOur First Look At MeiraGTx Holdings - Seeking Alpha
seekingalpha.com - January 27 at 6:51 PM
FDA grants Fast Track status to MeiraGTxs AAV-CNGA3 - Seeking AlphaFDA grants Fast Track status to MeiraGTx's AAV-CNGA3 - Seeking Alpha
seekingalpha.com - January 26 at 10:15 PM
MeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia - GlobeNewswireMeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia - GlobeNewswire
globenewswire.com - January 26 at 12:14 PM
MeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of AchromatopsiaMeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia
finance.yahoo.com - January 26 at 12:14 PM
MeiraGTx: Early Stage Gene Therapy Developer For Eye Diseases - Seeking AlphaMeiraGTx: Early Stage Gene Therapy Developer For Eye Diseases - Seeking Alpha
seekingalpha.com - January 19 at 1:55 PM
MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia - GlobeNewswireMeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia - GlobeNewswire
globenewswire.com - December 16 at 7:13 PM
MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced XerostomiaMeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia
finance.yahoo.com - December 16 at 7:13 PM
Is MGTX A Good Stock To Buy Now? - Yahoo FinanceIs MGTX A Good Stock To Buy Now? - Yahoo Finance
finance.yahoo.com - December 13 at 1:31 AM
Is MGTX A Good Stock To Buy Now?Is MGTX A Good Stock To Buy Now?
finance.yahoo.com - December 13 at 1:31 AM
MeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx ConferenceMeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
finance.yahoo.com - November 30 at 9:27 PM
Insider Buys MeiraGTx Stock - Yahoo FinanceInsider Buys MeiraGTx Stock - Yahoo Finance
finance.yahoo.com - November 25 at 12:50 AM
Insider Buys MeiraGTx Stock - BenzingaInsider Buys MeiraGTx Stock - Benzinga
benzinga.com - November 24 at 2:49 PM
Insider Buys MeiraGTx StockInsider Buys MeiraGTx Stock
finance.yahoo.com - November 24 at 2:49 PM
MeiraGTx to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference - Yahoo FinanceMeiraGTx to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference - Yahoo Finance
finance.yahoo.com - November 23 at 11:48 PM
MeiraGTx to Participate in the Piper Sandler 32nd Annual Virtual Healthcare ConferenceMeiraGTx to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 23 at 6:47 PM
Why MeiraGTx Holdings Stock Is Down Today - Motley FoolWhy MeiraGTx Holdings Stock Is Down Today - Motley Fool
fool.com - November 19 at 8:34 PM
Why MeiraGTxs Stock Is Trading Lower Today - BenzingaWhy MeiraGTx's Stock Is Trading Lower Today - Benzinga
benzinga.com - November 19 at 3:34 PM
Why MeiraGTx Holdings Stock Is Down Today - NasdaqWhy MeiraGTx Holdings Stock Is Down Today - Nasdaq
nasdaq.com - November 19 at 3:34 PM
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares - GlobeNewswireMeiraGTx Announces Pricing of Public Offering of Ordinary Shares - GlobeNewswire
globenewswire.com - November 19 at 3:34 PM
MeiraGTx slides on public offering pricing at $12.85/shareMeiraGTx slides on public offering pricing at $12.85/share
seekingalpha.com - November 19 at 8:37 AM
MeiraGTx -2% after hours on 5M shares offering - Seeking AlphaMeiraGTx -2% after hours on 5M shares offering - Seeking Alpha
seekingalpha.com - November 18 at 7:34 PM
MeiraGTx Announces Proposed Public Offering of Ordinary Shares - GlobeNewswireMeiraGTx Announces Proposed Public Offering of Ordinary Shares - GlobeNewswire
globenewswire.com - November 18 at 7:34 PM
MeiraGTxs gene therapy shows sustained benefit in inherited retinal disorderMeiraGTx's gene therapy shows sustained benefit in inherited retinal disorder
seekingalpha.com - November 16 at 7:42 PM
Form 8-K MeiraGTx Holdings plc For: Nov 13 - StreetInsider.comForm 8-K MeiraGTx Holdings plc For: Nov 13 - StreetInsider.com
streetinsider.com - November 16 at 2:41 PM
MeiraGTx Announces Investigational Gene Therapy Continues to Demonstrate Statistically Significant Improvement in Vision in Patients with X-Linked Retinitis Pigmentosa One Year After Treatment - GlobeNewswireMeiraGTx Announces Investigational Gene Therapy Continues to Demonstrate Statistically Significant Improvement in Vision in Patients with X-Linked Retinitis Pigmentosa One Year After Treatment - GlobeNewswire
globenewswire.com - November 13 at 8:45 PM
MeiraGTx Announces Investigational Gene Therapy Continues to Demonstrate Statistically Significant Improvement in Vision in Patients with X-Linked Retinitis Pigmentosa One Year After TreatmentMeiraGTx Announces Investigational Gene Therapy Continues to Demonstrate Statistically Significant Improvement in Vision in Patients with X-Linked Retinitis Pigmentosa One Year After Treatment
finance.yahoo.com - November 13 at 8:45 PM
MeiraGTx to Present at the Barclays Gene Editing & Gene Therapy Summit - Yahoo FinanceMeiraGTx to Present at the Barclays Gene Editing & Gene Therapy Summit - Yahoo Finance
finance.yahoo.com - November 10 at 4:55 PM
MeiraGTx to Present at the Barclays Gene Editing & Gene Therapy SummitMeiraGTx to Present at the Barclays Gene Editing & Gene Therapy Summit
finance.yahoo.com - November 10 at 4:55 PM
Earnings Update: MeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported And Analysts Are Boosting Their Estimates - Yahoo FinanceEarnings Update: MeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance
finance.yahoo.com - November 10 at 6:54 AM
Upgrade: Analysts Just Made A Huge Increase To Their MeiraGTx Holdings plc (NASDAQ:MGTX) Forecasts - Yahoo FinanceUpgrade: Analysts Just Made A Huge Increase To Their MeiraGTx Holdings plc (NASDAQ:MGTX) Forecasts - Yahoo Finance
finance.yahoo.com - November 10 at 6:54 AM
Upgrade: Analysts Just Made A Huge Increase To Their MeiraGTx Holdings plc (NASDAQ:MGTX) ForecastsUpgrade: Analysts Just Made A Huge Increase To Their MeiraGTx Holdings plc (NASDAQ:MGTX) Forecasts
finance.yahoo.com - November 10 at 6:54 AM
MeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their EstimatesMeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
nasdaq.com - November 8 at 7:26 PM
Earnings Update: MeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported And Analysts Are Boosting Their EstimatesEarnings Update: MeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported And Analysts Are Boosting Their Estimates
finance.yahoo.com - November 8 at 2:25 PM
MeiraGTx EPS beats by $0.52, beats on revenueMeiraGTx EPS beats by $0.52, beats on revenue
seekingalpha.com - November 7 at 8:21 AM
MeiraGTx Reports Third Quarter 2020 Financial Results Nasdaq:MGTX - GlobeNewswireMeiraGTx Reports Third Quarter 2020 Financial Results Nasdaq:MGTX - GlobeNewswire
globenewswire.com - November 5 at 8:44 AM
MeiraGTx Reports Third Quarter 2020 Financial ResultsMeiraGTx Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 5 at 8:44 AM
MeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at AAO 2020 Virtual Meeting - StreetInsider.comMeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at AAO 2020 Virtual Meeting - StreetInsider.com
streetinsider.com - October 29 at 7:03 PM
MeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at AAO 2020 Virtual Meeting - BenzingaMeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at AAO 2020 Virtual Meeting - Benzinga
benzinga.com - October 29 at 2:02 PM
MeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at AAO 2020 Virtual Meeting - Yahoo FinanceMeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at AAO 2020 Virtual Meeting - Yahoo Finance
finance.yahoo.com - October 28 at 6:35 PM
MeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at AAO 2020 Virtual MeetingMeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at AAO 2020 Virtual Meeting
finance.yahoo.com - October 28 at 6:34 PM
Should I Buy MeiraGTx Holdings plc (MGTX)? - Yahoo FinanceShould I Buy MeiraGTx Holdings plc (MGTX)? - Yahoo Finance
finance.yahoo.com - October 14 at 1:47 PM
What Does The Future Hold For MeiraGTx Holdings plc (NASDAQ:MGTX)? These Analysts Have Been Cutting Their EstimatesWhat Does The Future Hold For MeiraGTx Holdings plc (NASDAQ:MGTX)? These Analysts Have Been Cutting Their Estimates
finance.yahoo.com - October 13 at 10:22 PM
What Does The Future Hold For MeiraGTx Holdings plc (NASDAQ:MGTX)? These Analysts Have Been Cutting Their Estimates - Yahoo FinanceWhat Does The Future Hold For MeiraGTx Holdings plc (NASDAQ:MGTX)? These Analysts Have Been Cutting Their Estimates - Yahoo Finance
finance.yahoo.com - October 7 at 2:20 PM
MeiraGTx Announces Nine-Month Data from Phase 1/2 Trial of AAV-RPGR Demonstrating Significant and Sustained Vision Improvement in X-Linked Retinitis Pigmentosa (XLRP) - GlobeNewswireMeiraGTx Announces Nine-Month Data from Phase 1/2 Trial of AAV-RPGR Demonstrating Significant and Sustained Vision Improvement in X-Linked Retinitis Pigmentosa (XLRP) - GlobeNewswire
globenewswire.com - October 3 at 12:23 PM
Seeking Alpha Catalyst Watch - Seeking AlphaSeeking Alpha Catalyst Watch - Seeking Alpha
seekingalpha.com - October 2 at 8:24 PM
This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.